Skip to main content
. 2021 Apr 16;182:648–658. doi: 10.1016/j.ijbiomac.2021.04.005

Table 2.

A list of virosome based formulation.

Target Vaccine composition Status Dosage form Ref
Respiratory Syncytial Virus (RSV) Virosomes, HA, NA, RSV fusion proteins Under GMP8 IM [58]
HIV-1 Virosomes, HA, NA, P1, gp41, TLR7/81 New GMP Mucose [57]
Hepatitis A Virosomes, HA, NA, HAV2 Marketed Injection [59]
Influenza Virosomes HA, NA Marketed Injection [53]
Plasmodium falciparum Virosomes, AMA-13, CSP4, PfCyRPA5 Phase I/II Injection [60,61]
Melanoma Virosomes, Recombinant vaccinia virus encoding five melanoma epitopes, octo-mel-rVV6 Phase I/II Intradermal [62]
SARS-CoV-2 Virosomes HA, NA, s protein8 Phase I/II Injection

Abbreviations: 1. Tool like receptor 7/8, 2. Inactivated hepatitis A virus, 3. Apical membrane antigen 1, 4. Circumsporozoite protein, 5. Plasmodium falciparum cysteine-rich protective antigens, 6. Three co-stimulatory molecules, 7. Spike protein, 8. Good manufacturing practice.